N@N

David Toung Upgraded (ABBV) to Strong Buy and Held Target at $115 on, Jun 2nd, 2020

David Toung of Argus Research, Upgraded "AbbVie Inc." (ABBV) to Strong Buy and Held Target at $115 on, Jun 2nd, 2020.

David has made no other calls on ABBV in the last 4 months.

There are 8 other peers that have a rating on ABBV. Out of the 8 peers that are also analyzing ABBV, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Jason Gerberry of "B of A Securities" Initiated at Hold and Held Target at $95 on, Monday, May 18th, 2020
• Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Monday, March 23rd, 2020

These are the ratings of the 6 analyists that currently disagree with David

---

• David Risinger of "Morgan Stanley" Initiated at Buy and Held Target at $95 on, Monday, May 11th, 2020
• Geoffrey Porges of "SVB Leerink" Maintained at Buy with Increased Target to $122 on, Monday, May 11th, 2020
• Randall Stanicky of "RBC Capital" Maintained at Buy with Increased Target to $98 on, Monday, May 4th, 2020
• Vamil Divan of "Mizuho" Maintained at Strong Buy with Increased Target to $101 on, Monday, May 4th, 2020
• Navin Jacob of "UBS" Maintained at Strong Buy with Decreased Target to $96 on, Monday, April 13th, 2020
• Steve Scala of "TD Cowen" Maintained at Buy with Increased Target to $105 on, Tuesday, February 18th, 2020

Contributing Sources

---